Verified peer comparison
AbCellera Biologics Inc. - Common Shares vs Recursion Pharmaceuticals, Inc. - Class A Common Stock Financial Comparison
AbCellera Biologics Inc. - Common Shares versus Recursion Pharmaceuticals, Inc.…
Direct answer
AbCellera Biologics Inc. - Common Shares and Recursion Pharmaceuticals, Inc. - Class A Common Stock are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free AbCellera Biologics Inc. - Common Shares email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- AbCellera Biologics Inc. - Common Shares Revenue
- 75,128,000 USD
- Recursion Pharmaceuticals, Inc. - Class A Common Stock Revenue
- 74,681,000 USD
- AbCellera Biologics Inc. - Common Shares Operating income
- -217,103,000 USD
- Recursion Pharmaceuticals, Inc. - Class A Common Stock Operating income
- -648,132,000 USD